Nedaplatin是顺铂的衍生物，是一种DNA损伤剂，可诱导肾毒性。
Cas No.:95734-82-0
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Nedaplatin is a derivative of cisplatin and a DNA damage agent that can induce nephrotoxicity [1]. Nedaplatin enters cells through various transport proteins to bind to DNA, causing DNA distortion and damaging the DNA structure, and stimulates the production of reactive oxygen species, thereby inducing cellular oxidative stress[2]. Nedaplatin has been widely used to kill the proliferation of various tumor cells and has been employed to develop combined therapies to effectively inhibit tumor growth[3].
In vitro, Nedaplatin treatment for 48 hours significantly promoted cell death in HNE1 and CNE2 cells, with IC50 values of 2.75μg/ml and 1.49μg/ml, respectively[4]. Treatment with 10μg/ml Nedaplatin for 48 hours significantly induced apoptosis in SKOV3 cells, caused cell cycle arrest, accompanied by an increase in the expression of Bax, caspase-3 and caspase-9, and a decrease in the expression of Bcl-2 and MMP-2[5]. Treatment with 20μM Nedaplatin combined with 5μM ABT-737 for 48 hours led to depolarization of the mitochondrial membrane in A549 cells, promoting the degradation of Mcl-1 protein and the release of cytochrome c[6].
In vivo, Nedaplatin treatment via a single intravenous injection at a dose of 15mg/kg significantly induced the death of 15-week-old male rats within 10 days, and caused weight loss and kidney damage in the rats[7]. A single intravenous injection of 20mg/kg dose of Nedaplatin significantly induced tumor growth in a xenograft mouse model of Ma44 cells within 12 days [8].
References:
[1] Shimada M, Itamochi H, Kigawa J. Nedaplatin: a cisplatin derivative in cancer chemotherapy[J]. Cancer management and research, 2013: 67-76.
[2] Szupryczyński K, Szefler B. Interactions of Nedaplatin with Nucleobases and Purine Alkaloids: Their Role in Cancer Therapy[J]. Biomedicines, 2025, 13(7): 1551.
[3] Su X Y, Yin H T, Li S Y, et al. Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro[J]. Asian Pacific Journal of Cancer Prevention, 2012, 13(9): 4531-4536.
[4] Liu Z, Liu J, Li L, et al. Inhibition of autophagy potentiated the antitumor effect of nedaplatin in cisplatin-resistant nasopharyngeal carcinoma cells[J]. PloS one, 2015, 10(8): e0135236.
[5] Li W, Hanfeng L, Zhengwen C, et al. Nedaplatin Induced Apoptosis in Human Ovarian Cancer Cisplatin-resistant Cell Lines in vitro and Investigated Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2012, 39(10): 1216-1220.
[6] Zhang C, Li Y L, Weng X, et al. Nedaplatin enhanced apoptotic effects of ABT-737 in human cancer cells via Mcl-1 inhibition[J]. Oncology Letters, 2016, 12(5): 4195-4202.
[7] Uehara T, Watanabe H, Itoh F, et al. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats[J]. Archives of toxicology, 2005, 79(8): 451-460.
[8] Matsumoto M, Takeda Y, Maki H, et al. Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer[J]. Japanese Journal of Cancer Research: Gann, 2001, 92(1): 51.
Nedaplatin是顺铂的衍生物，是一种DNA损伤剂，可诱导肾毒性[1]。Nedaplatin可通过多种转运蛋白进入细胞，然后与DNA结合，导致DNA扭曲并破坏DNA结构，同时刺激活性氧的产生，从而诱导细胞氧化应激[2]。Nedaplatin已被广泛用于杀伤多种肿瘤细胞的增殖，并已被用于开发联合疗法以有效抑制肿瘤生长[3]。
在体外，Nedaplatin处理48小时显著促进了HNE1和CNE2细胞的死亡，IC50值分别为2.75μg/ml和1.49μg/ml [4]。使用10μg/ml的Nedaplatin处理SKOV3细胞48小时，显著诱导了细胞凋亡，引起了细胞周期阻滞，同时伴随Bax、caspase-3和caspase-9表达升高，以及Bcl-2和MMP-2表达降低[5]。使用20μM的Nedaplatin联合5μM的ABT-737处理A549细胞48小时，导致线粒体膜去极化，促进了Mcl-1蛋白降解和细胞色素c释放[6]。
在体内，单次静脉注射15mg/kg剂量的Nedaplatin，在10天内显著诱导了15周龄雄性大鼠的死亡，并导致大鼠体重下降和肾脏损伤[7]。单次静脉注射20mg/kg剂量的Nedaplatin，在12天内显著促进了Ma44细胞异种移植小鼠模型中的肿瘤生长[8]。
| Cell experiment [1]: | |
Cell lines | HNE1 cells |
Preparation Method | HNE1 cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 2mM L-glutamine, 100U/ml penicillin, 100μg/ml streptomycin in a humidified incubator at 37°C and 5% CO2. HNE1 cells were plated at a density of 6×103 cells/ml in a 96-well plate with growth medium for 24h, and then were incubated with the different concentrations of Nedaplatin (0, 1.5, 3, 6, 12, and 24 μg/ml) for 48 h, and the cell viability was analyzed. |
Reaction Conditions | 0, 1.5, 3, 6, 12, and 24μg/ml; 48h |
Applications | Nedaplatin treatment significantly inhibited cell viability of HNE1 cells in a concentration-dependent manner. |
| Animal experiment [2]: | |
Animal models | Athymic BALB/c nude mice |
Preparation Method | Female athymic BALB/c nude mice (7-week-old) were housed in an air-conditioned room with a 12h light/dark cycle and received standard laboratory rat chow and tap water. On day 0, Ma44 cells (5×105) were implanted s.c. into the back of BALB/c nude mice. Treatment was started when the tumor volume reached 100mm3. A single intravenous injection of 20mg/kg dose of Nedaplatin. Tumor size was scored throughout the experiment. |
Dosage form | 20mg/kg for once; i.v. |
Applications | Nedaplatin treatment reduced tumor volume in mice carrying Ma44 xenograft tumors. |
References: | |
| Cas No. | 95734-82-0 | SDF | |
| 别名 | 奈达铂,NSC 375101D | ||
| 化学名 | azanide;2-hydroxyacetic acid;platinum(2+) | ||
| Canonical SMILES | C(C(=O)O)O.[NH2-].[NH2-].[Pt+2] | ||
| 分子式 | C2H8N2O3Pt | 分子量 | 303.17 |
| 溶解度 | ≥ 9.8mg/mL in Water | 储存条件 | Store at -20°C,unstable in solution, ready to use. |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.2985 mL | 16.4924 mL | 32.9848 mL |
| 5 mM | 659.7 μL | 3.2985 mL | 6.597 mL |
| 10 mM | 329.8 μL | 1.6492 mL | 3.2985 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet